Chemotherapy Doctors in Turkey — Page 2

Professor Seref Komurcu has authored over 110 scientific papers and holds dual oncology certifications from the ECFMG in the USA and ESMO in Europe.

• Specialises in targeted chemotherapy protocols for breast, lung, and colorectal cancers
• Provides systemic therapies including immunotherapy with Keytruda for solid tumours
• Former Head of Medical Oncology at Gulhane Military Medical Academy
• Recognised for outstanding service and teaching excellence in oncology training
• Active member of the American Society of Clinical Oncology (ASCO)

Dr. Zulfu Sertkaya is an associate professor and andrologist at Andro Expertise in Istanbul. He holds the FEBU title from the European Association of Urology. Dr. Sertkaya focuses on male health, sexual function, and aesthetic urological procedures. He treats patients at his clinic and performs surgeries at affiliated hospitals.

• Earned Fellow of the European Board of Urology (FEBU) status.
• Specialize in andrology, male sexual health, and aesthetic urology.
• Performs penile implant surgery and varicocelectomy for infertility.
• Works at a clinic accredited by the Turkish Medical Association.

Professor Mustafa Özdoğan is the Head of Medical Oncology at Memorial Antalya Hospital and has performed over 900 cancer treatment procedures.

• Specialises in immunotherapy and genomic testing to target aggressive tumours
• Uses genetic testing to design personalised chemotherapy protocols for leukemia and solid tumours
• Completed advanced studies in minimally invasive cancer treatments and hyperthermia in Germany
• Holds dual memberships with the American Society of Clinical Oncology (ASCO) and ESMO

Professor Sadi Kerem Okutur is an award-winning oncologist who has performed 1,100 cancer treatments at Memorial Bahçelievler Hospital.

• Recipient of the Oncology Research Award from the Turkish Medical Oncology Association
• Expert in systemic therapies including chemotherapy, immunotherapy, and targeted molecular therapy
• Authored over 20 scientific papers and 10 book chapters on cancer care
• Former Associate Professor with residency training in both internal medicine and medical oncology
• Active member of the European Society for Medical Oncology

Professor Sezer Saglam is a leading medical oncologist at Gayrettepe Florence Nightingale Hospital, specialising in the complex field of gastrointestinal oncology.

• Served as Attending Physician in Gastrointestinal Oncology at the Istanbul University Oncology Institute
• Holds a prestigious fellowship in Medical Oncology from Istanbul University
• Member of the European Neuroendocrine Tumour Society (ENET)
• Active member of the American Society of Clinical Oncology (ASCO)
• Specialises in chemotherapy protocols for digestive system cancers

Dr. Eda Tanrikulu is a clinical oncologist at Anadolu Medical Center in Istanbul. She ranked 3rd nationally in Turkey's minor specialty medical exam. Dr. Tanrikulu specializes in chemotherapy and individualized cancer treatments. She works at a facility affiliated with the Johns Hopkins Hospital.

• Served as the head of the medical oncology unit at Haydarpaşa Numune Hospital.
• Participated in global training at Oxford University and ESMO in Manchester.
• Treats gastrointestinal, urological, lung, and breast cancers.
• Member of the American and European Societies of Medical Oncology.

Dr. Necdet Uskent is a medical oncologist and hematologist at Anadolu Medical Center in Istanbul. He was part of the pioneering team that performed Turkey's first bone marrow transplant. Dr. Uskent holds the European Medical Oncology Certificate and focuses on breast, lung, and gastrointestinal cancers. He works at a facility affiliated with Johns Hopkins Medicine.

• Founder of the Turkish Oncology Group (TOG).
• A founding member of the Turkish Society of Medical Oncology.
• Served as a visiting lecturer at Royal Free and University College Hospital in London.
• Treats complex hematological conditions including lymphomas and myeloma.

Assistant Professor Tahsin Ozadli has performed over 1,100 cancer treatments and currently leads the medical oncology team at Valued Med Hub Hospitals.

• Completed specialist medical oncology training at the Ankara Oncology Training and Research Hospital
• Focuses on gastrointestinal cases including oesophageal and gastric cancers
• Manages chemotherapy protocols for lung and breast cancer patients
• Known for a thorough approach to evaluating medical reports when planning treatments

Associate Professor Yusuf Acikgoz brings high-level expertise from The Ohio State University to Lokman Hekim University Ankara Hospital, where he has performed over 900 treatments.

• Holds specialist qualifications in both Internal Medicine and Medical Oncology
• Served as an investigator for major Phase III clinical trials including CheckMate-649
• Member of the American Society of Clinical Oncology (ASCO)
• Completed advanced immuno-oncology training through the Central European Cooperative Oncology Group in Vienna
• Awarded ECFMG and CITI certifications for high-standard clinical practice and research

Associate Professor Tahsin Ozatli is a leading medical oncologist at Istinye University Liv Hospital, where he focuses on targeted chemotherapy protocols for complex solid tumours.

• Specialises in treating breast, lung, and gastrointestinal cancers
• Promoted to Associate Professor for his academic contributions to oncology
• Trained in medical oncology at the Ankara Oncology Clinic
• Expertise includes managing tumours of the oesophagus and stomach
• Experienced in coordinating care within high-volume regional training hospitals

Professor Hasan Atilla Ozkan is the current President of the Turkish Society of Therapeutic Apheresis and a leading expert in haematological oncology.

• Holds specialist certifications in autologous and allogeneic stem cell transplantation
• Professor at Yeditepe University Faculty of Medicine – one of Turkey's top medical schools
• Completed an EBMT stem cell transplantation course for international clinical standards
• Awarded the Young Researcher Award at the 6th Turkish Therapeutic Apheresis Congress
• Active member of the European Bone Marrow Transplantation network (EBMT)

Professor Cemil Bilir is a highly regarded medical oncologist who has performed over 900 procedures and holds a PhD in inorganic chemistry.

• Completed a research fellowship at Northeastern University in Boston specialising in nanomedicine
• Served as a Professor of Medical Oncology at Sakarya University Faculty of Medicine
• Personally evaluates all patient materials to create personalised chemotherapy programmes
• Active member of the American Society of Clinical Oncology (ASCO) and ESMO

Associate Professor Hasan Mutlu leads medical oncology at Medical Park Antalya, specialising in personalised chemotherapy and next-generation genetic research.

• Expert in matching targeted cancer therapies and immunotherapy to a patient's specific genetic profile
• Former Associate Professor at Akdeniz University Faculty of Medicine
• Focuses on both organ tumour diagnosis and complementary medicine to support standard cancer treatments
• Completed advanced medical oncology training at Akdeniz University
• Practises at the JCI-accredited Medical Park Antalya Hospital Complex

Professor Irfan Cicin is a senior medical oncologist who leads complex chemotherapy programmes at İstinye University Liv Hospital Topkapı.

• Held the rank of Professor of Medical Oncology at Trakya University Faculty of Medicine since 2015
• Trained at Istanbul University Cerrahpaşa – one of Turkey's most prestigious medical institutions
• Specialises in designing personalised internal medicine protocols for diverse tumour types
• Served as Associate Professor for five years training the next generation of cancer specialists

Associate Professor Muhammed Mustafa Atci is a leading medical oncologist at İstinye University Liv Hospital Topkapı, where he serves as an education coordinator for future specialists.

• Recognised for his clinical research on triple-negative breast cancer and adjuvant chemotherapy protocols
• Specialises in treating colon and lung cancers using evidence-based chemotherapy programmes
• Member of the American Society of Clinical Oncology (ASCO) since 2018
• Published extensive research on BRCA mutation profiles and hereditary cancer risks
• Expert in managing chemotherapy outcomes for elderly patients and those with complex comorbidities

Professor Mustafa Serkan Alemdar is a dual-specialised medical oncologist and internal medicine expert at the JCI-accredited Medical Park Antalya Hospital Complex.

• Specialised in medical oncology at Akdeniz University Faculty of Medicine
• Managed complex cases at Antalya Training and Research Hospital
• Treats a wide range of solid tumours with personalised chemotherapy protocols
• Focuses on evidence-based medicine within a multidisciplinary oncology team
• Experienced in balancing high-intensity treatments with patient symptom management

Associate Professor Tarik Salman brings high-level expertise from top international institutions, including research and clinical roles at Moffitt Cancer Center and Memorial Sloan Kettering Cancer Center in the USA.

• Specialises in comprehensive genomic profiling to create individualised treatment plans
• Uses targeted therapies and immunotherapy alongside standard chemotherapy protocols
• Active board member of the Geriatric Oncology Association and Mediterranean Oncology Association
• Member of the American Society of Clinical Oncology since 2008
• Expert in managing rare cancers and clinical research cases

Dr Ercan Ozden completed his medical oncology subspecialisation at Kocaeli University following a thorough double-specialisation track. He treats patients at VM Medical Park Pendik Hospital with a focus on evidence-based chemotherapy protocols.

• Trained at Istanbul University Cerrahpasa Faculty of Medicine in the competitive English Medical Program
• Completed five years of specialist training in Internal Medicine before pursuing oncology
• Gained experience in high-volume medical oncology at Sirnak State Hospital
• Focuses on managing complex chemotherapy regimes for various cancer types